Percutaneous radiofrequency ablation of ovarian cancer metastasis to the liver: indications, outcomes, and role in patient management.
OBJECTIVE
Stages III and IV ovarian cancer are treated with a combination of chemotherapy and resection, in some cases including second and third surgical procedures, to achieve cytoreduction. Percutaneous radiofrequency ablation has proved effective in local control of hepatic tumors. We report early experience with percutaneous radiofrequency ablation in the management of isolated foci of metastatic ovarian cancer and assess the efficacy of the technique in achieving and maintaining local control by percutaneous cytoreduction.


CONCLUSIONS
Percutaneous radiofrequency ablation is effective in achieving local control in selected patients with metastasis from ovarian cancer. In patients with limited macroscopic disease, cytoreduction can be achieved without surgery.
Gervais
Debra A
DA
Department of Radiology, Massachusetts General Hospital, 55 Fruit St., White 270, Boston, MA 02114, USA.
Arellano
Ronald S
RS
Mueller
Peter R
PR
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017115:Catheter Ablation / Q000379:methods*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary* / Q000601:surgery*; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000473:pathology*; D012189:Retrospective Studies; D016896:Treatment Outcome